Categories: News

Point of Care Decision Support Announces Partnership with CoaguSense, Inc.

ST. PAUL, Minn., April 10, 2019 /PRNewswire/ — Point of Care Decision Support (PCDS), developer of an integrated electronic clinical decision support software for comprehensive individual patient care management and complex medication paradigms for patients with severe, chronic conditions; and CoaguSense, Inc., manufacturer of the world’s most precise portable PT/INR monitoring system using direct mechanical clot detection for patients on an anticoagulant therapy announce their strategic partnership. 

This agreement brings together the leading evidence-based anticoagulation software that improves clinical outcomes and optimizes patient care and the recently FDA cleared Coag-Sense® PT2 PT/INR Monitoring System – a new compact PT/INR meter that allows clinicians and patients to connect to the PCDS patient management solution.  Together they help streamline the care workflow while allowing the clinician and patient to make informed decisions together about their anticoagulant therapy.

PCDS President and CEO, Jaime Ojeda says, “CoaguSense is a great partner for PCDS because its Coag-Sense meter is simple to use and offers a wide variety of connectivity solutions including Wi-Fi and Bluetooth. Our clients continue to strive for more comprehensive home monitoring solutions to better care for their patients; the PCDS and CoaguSense partnership enables patients and their care providers to drive better outcomes in the new era of digital health.”   

CoaguSense CEO, Doug Patterson contributes, “PCDS fills a significant unmet need by offering a comprehensive patient anticoagulation management solution that can easily and affordably be implemented by all care providers, even smaller physician practices.”

Point of Care Decision Support and CoaguSense will be demonstrating their products at the upcoming AC Forum Conference for physicians, nurses and pharmacists that work with patients on oral anticoagulant therapies in Fort Lauderdale, Florida, April 11-13.  Point of Care will hold a Symposium titled, “How Evidence-Derived Clinical Decision Support within Electronic Health Records Can Improve Delivery of Optimized Anticoagulant Therapy: The Point of Care AC Decision Support Experience” and welcome any conference attendees to register.

About Point of Care Decision Support
Point of Care Decision Support, LLC (PCDS) is a healthcare software company driving healthcare quality across the continuum of care.  With its Dynamic Decision Support Platform as a core anchor, PCDS builds intuitive healthcare tools that measure and improve the quality of patient care, provide real-time data and analysis, and have a meaningful and measurable return on investment.  Interoperable with all major EMR systems, the applications easily integrate new technology with existing investments, reducing implementation and operating costs.  PCDS believes that the complexity of patient care can be captured in a clear and meaningful way, enabling informed decision-making throughout the coordination and management of care. Visit www.ptofcare.com to learn more about their anticoagulation (AC), asthma and other chronic disease applications in their solutions portfolio.

About CoaguSense, Inc.
Based in Fremont, California, CoaguSense was founded in 2008 to bring more accurate and robust anticoagulation monitoring technology to both clinicians and patients. The company’s lead product is the Coag-Sense PT/INR Monitoring System, which incorporates a novel direct micromechanical clot-detection technology. This proprietary technology emulates the World Health Organization (WHO) gold standard tilt-tube method while requiring only a very small blood sample. Direct clot-detection technology provides clinicians with the system reliability they demand and patients with the comfort of knowing that proper home testing can provide dependable results like a laboratory. In 2016, CoaguSense was acquired by i-SENS, Inc.—a leader in point-of-care diagnostic technology and manufacturing. Further information about CoaguSense can be found at www.coag-sense.com.

Coag-Sense is a registered trademark of CoaguSense. All other trademarks are the property of their respective owners.

Media Contact:

Karen Beran                                                                                                    
Point of Care Decision Support, LLC                                                                      
212577@email4pr.com
952-446-7724

Melissa Gonzalez
CoaguSense, Inc
212577@email4pr.com
201-589-0291

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/point-of-care-decision-support-announces-partnership-with-coagusense-inc-300830017.html

SOURCE Point of Care Decision Support & CoaguSense, Inc.

Staff

Recent Posts

New Campaign Encourages Hispanic Parents to Store Their Firearms Safely

Brady, Casanova//McCann and the Ad Council partner for the first national Spanish language public education…

2 hours ago

AMSBIO and Bioz Combine Efforts to Empower the Scientific Community With Citation Data

PALO ALTO, CA / ACCESSWIRE / June 26, 2024 / Bioz, Inc., a pioneer in…

2 hours ago

Medexus Generates Record Revenue of US$113.1 Million in Fiscal Year 2024

FDA has Accepted for Review the Treosulfan NDAManagement to host conference call at 8:00 AM…

14 hours ago

Groundbreaking Ecosystem Map Reveals Innovative Collaborations, Care Pathways, and Technologies for Dementia

CHICAGO, June 25, 2024 /PRNewswire/ -- A new Journal of Alzheimer's Disease article unveils an…

14 hours ago

The Kevin Trudeau Show Expands to Twice Weekly Following a Much-Awaited Return

CHICAGO, June 25, 2024 /PRNewswire/ -- Following a triumphant return as a weekly broadcast, The…

14 hours ago

Neonode Announces Adjournment of Reconvened Annual Meeting of Stockholders

STOCKHOLM, June 25, 2024 /PRNewswire/ -- Neonode Inc. (NASDAQ: NEON), announced today that its 2024…

14 hours ago